Skip to main content
Abrdn PLC logo

Abrdn PLC — Investor Relations & Filings

Ticker · ABDN ISIN · GB00BF8Q6K64 LEI · 0TMBS544NMO7GLCE7H90 IL Financial and insurance activities
Open in API
Filings indexed 4,550 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country GB United Kingdom
Listing IL ABDN

About Abrdn PLC

https://www.abrdn.com/en-gb

Abrdn PLC is a global investment company and asset manager formed from the 2017 merger of Standard Life and Aberdeen Asset Management. The firm offers a range of investment solutions, funds, and investment trusts. It serves a diverse client base that includes individual customers, financial advisers, wealth managers, and institutional investors. The company focuses on providing expertise and tools to help clients manage and grow their wealth, enabling them to prepare for their financial future.

Recent filings

Filing Released Lang Actions
Form 8.3 - Stagecoach Group plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider/significant shareholder activity during a takeover situation (mentioning Stagecoach Group plc and National Express Group plc). While it contains dealing information, its primary function is a mandatory disclosure related to a takeover under specific regulatory rules, which is a form of regulatory announcement. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate general category is 'Regulatory Filings' (RNS). It is not a Director's Dealing (DIRS) as it pertains to a general disclosure under the Takeover Code, not just director transactions, nor is it a general M&A Activity (TAR) announcement, but a specific disclosure *during* M&A activity.
2022-01-06 English
Form 8.3 - Sanne Group plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offeror/offeree (Sanne Group plc). This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity (similar to DIRS), the specific context of a Takeover Code disclosure (Form 8.3) is a specialized regulatory filing related to M&A activity or significant ownership shifts during an offer period. Given the options, 'Director's Dealing' (DIRS) covers personal transactions by executives, but this filing is specifically mandated by the Takeover Code regarding interests in securities during an offer. Since there isn't a specific 'Takeover Disclosure' code, and it details dealings by a major shareholder (abrdn plc) in relation to an offer, it is most closely related to insider/major shareholder activity. However, the most fitting general category for mandatory regulatory disclosures that aren't standard financial reports (10-K, IR, ER) or specific governance/dividend notices is 'Regulatory Filings' (RNS), as it is a mandatory filing disseminated via RNS. Given the specific nature of the content (Takeover Code disclosure), it is a highly specific regulatory filing. If we must choose from the provided list, 'DIRS' covers insider trades, but this is broader (major shareholder disclosure during an offer). 'RNS' is the best fit as a general regulatory filing disseminated through the RNS system, especially since it doesn't fit the M&A (TAR) or Director's Dealing (DIRS) definitions perfectly, although it is related to both. Since it is a mandatory disclosure disseminated via RNS, I will classify it as RNS, the general regulatory filing fallback.
2022-01-06 English
Form 8.3 - Ultra Electronics Holdings plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offeror/offeree (Ultra Electronics Holdings plc). This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity, the specific context of a Takeover Code disclosure (Form 8.3) is not explicitly covered by 'DIRS' (Director's Dealing, which usually implies routine insider trades under general securities law) or 'MRQ' (Major Shareholding Notification, which is typically for holdings above a general threshold, not specifically takeover-related disclosures). Since it is a specific regulatory filing related to a takeover process, and it doesn't fit perfectly into the other specific categories like DIV, ER, or 10-K, the most appropriate general regulatory category that captures specific, non-standard regulatory announcements is 'RNS' (Regulatory Filings), as it is a mandatory filing under the Takeover Code and is distributed via RNS.
2022-01-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a notification filed via RNS (Regulatory News Service) as indicated by the RNS Number and the closing statement. The content explicitly states the 'Total number of voting rights and capital' as of a specific date (31 December 2021) and references the FCA's Disclosure Guidance and Transparency Rule 5.6.1. This type of mandatory disclosure regarding the total number of shares carrying voting rights is a specific regulatory announcement. While it relates to capital structure, it is not a general financing update (CAP) or a share issue/change announcement (SHA), but rather a periodic regulatory disclosure about voting rights denominator. This fits best under the general 'Regulatory Filings' (RNS) category, as it is a standard, required regulatory update that doesn't match the more specific definitions like DIV, DVA, or SHA, although it is closely related to DVA (Declaration of Voting Results). Given the context of RNS distribution and the nature of the disclosure (voting rights denominator), RNS is the most appropriate general classification for this type of mandatory regulatory update.
2022-01-04 English
Form 8.3 - Clinigen Group plc
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' in the context of an offer (here, involving Clinigen Group plc). This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity (similar to DIRS), the specific context of the Takeover Code disclosure (Form 8.3) is a specialized regulatory filing related to M&A activity or significant ownership shifts during a bid. Since there is no specific code for 'Takeover Code Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate classification is 'Regulatory Filings' (RNS) as a general regulatory announcement, or potentially 'Director's Dealing' (DIRS) if the focus is purely on the insider nature, but RNS is broader for mandatory regulatory forms. Given the context of a takeover bid (implied by the form type), it is a specific regulatory disclosure. I will classify it as RNS as it is a mandatory filing disseminated through the RNS system concerning a specific event (takeover/dealing disclosure).
2021-12-24 English
Form 8.3 - Clinigen Group plc
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offer for 'Clinigen Group plc'. This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity (similar to DIRS), Form 8.3 is a specific regulatory filing mandated by the Takeover Code, which falls under the general category of regulatory announcements or specific insider transaction reporting. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting personal share transactions by executives/insiders, although this specific form (8.3) is mandatory during takeover bids. Since DIRS covers personal share transactions by directors/executives, and this document details abrdn plc's position and dealing in the securities of an offeree company, DIRS is the most appropriate specific classification among the choices provided for insider/director-related transaction reporting, even though it is triggered by a takeover context. If DIRS was not available, RNS would be the fallback. However, DIRS specifically covers executive/director transactions.
2021-12-23 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.